Cancer Care
Bone Marrow Transplant Cost in India
Autologous and allogeneic bone marrow transplant costs in India, donor matching, isolation stay, and what treatment for leukaemia and thalassaemia involves.
Bone Marrow Transplant cost in India
Accredited hospitals in India quote $18,000 – $42,000 as an inpatient package for this procedure. Where you sit in that band depends on the hospital, the surgeon, the implant or drug protocol and the room category you choose.
| Country | Indicative package range (USD) | Versus India |
|---|---|---|
| India | $18,000 – $42,000 | |
| Turkey | $40,000 – $70,000 | |
| United Arab Emirates | $120,000 – $180,000 | |
| United Kingdom (private) | $150,000 – $250,000 | |
| United States | $300,000 – $800,000 |
What the procedure involves
Bone marrow transplantation replaces diseased marrow with healthy stem cells. An autologous transplant uses the patient's own cells and is used mainly for myeloma and some lymphomas. An allogeneic transplant uses cells from a matched sibling, a matched unrelated donor or a half-matched family member (haploidentical), and is used for leukaemia, aplastic anaemia, thalassaemia and sickle cell disease.
For families travelling from Africa, the Middle East and South Asia, thalassaemia and sickle cell disease are the commonest reasons to seek transplantation, and India has one of the largest paediatric transplant experiences in the world. The determining factor is donor availability: a fully matched sibling gives the best outcome, while haploidentical transplantation from a parent has widened access considerably at a higher complication rate.
What the package includes and excludes
Typically included
- Surgeon, anaesthetist and assisting team fees
- Operating theatre and recovery-room charges
- Stated number of ICU and ward days in the quoted room category
- Routine pre-operative investigations and anaesthetic clearance
- Medicines, consumables and dressings during admission
- Daily inpatient physiotherapy where clinically indicated
- One post-discharge review with the operating surgeon
- Airport pickup, interpreter support and a named case manager
- HLA typing for patient and family donors
- Conditioning chemotherapy, stem cell harvest and infusion
- Isolation-unit stay, transfusion support and antimicrobial cover during admission
Not included
- Flights, visa fees and accommodation outside the hospital
- Extended ICU or ward stay beyond the quoted days
- Blood and blood products, if required
- Management of complications and unplanned re-operation
- Treatment of unrelated pre-existing conditions found during workup
- Medicines and investigations after discharge
- Unrelated-donor registry search and stem cell procurement fees
- Treatment of severe graft-versus-host disease or prolonged ICU care
- Post-discharge medication and outpatient transfusion support
Recovery and trip timeline
Week 1–2
Conditioning chemotherapy and stem cell infusion in a protected isolation unit.
Week 3–5
Engraftment period with counts at their lowest; transfusion and antimicrobial support.
Week 6–10
Discharge to a nearby serviced apartment with near-daily outpatient review.
Week 11–14
Immune reconstitution monitored; travel home approved once counts are stable.
Year 1
Graft-versus-host disease surveillance, re-vaccination schedule, staged return to school or work.
What drives a good outcome
- Degree of HLA match — a fully matched sibling donor gives the best outcome by a wide margin.
- Transplanting early, before iron overload or organ damage accumulates in thalassaemia.
- Strict infection control during the neutropenic phase, including family training.
- Staying near the centre for the full outpatient period rather than travelling home early.
Answers
Frequently asked questions
Next step
Get a free cost estimate
Send your reports and we will return a written opinion and an itemised package estimate from accredited hospitals in India. A named case manager replies within 24 hours, every day of the week.